Who owns MOLECULIN BIOTECH INC COM?
- Ticker: MBRX
- CUSIP Number: 60855d309
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 156k | $549k | 5% | Jun 2024 |
|
| Vanguard Group | 84k | $297k | 12% | Jun 2024 |
|
| LPL Financial | 36k | $103k | 7% | Sep 2024 |
|
| Geode Capital Management | 22k | $62k | 10% | Sep 2024 |
|
| BlackRock | 13k | $35k | 100% | Sep 2024 |
|
| BlackRock | 13k | $44k | 0% | Jun 2024 |
|
| Renaissance Technologies | 11k | $31k | 100% | Sep 2024 |
|
| Atticus Wealth Management | 3.3k | $9.5k | 0% | Sep 2024 |
|
| Tower Research Capital | 2.0k | $7.0k | 221% | Jun 2024 |
|
| Newbridge Financial Services Group | 1.4k | $3.9k | 0% | Sep 2024 |
|
| Morgan Stanley | 426.00 | $1.5k | 1% | Jun 2024 |
|
| Bank of America Corporation | 143.00 | $405.161900 | 411% | Sep 2024 |
|
| Sandy Spring Bank | 89.00 | $253.000300 | 0% | Sep 2024 |
|
| CVA Family Office | 34.00 | $96.998600 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 23.00 | $65.000300 | -65% | Sep 2024 |
|
| North Star Investment Management | 17.00 | $47.999500 | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $3.000000 | -83% | Sep 2024 |
|
| Royal Bank of Canada | 1.00 | $0 | -90% | Sep 2024 |
|
Who sold out of Moleculin Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goss Wealth Management | Mar 2024 | 1.00 | $6.000000 |